CAPTRUST Financial Advisors
PRAX icon

CAPTRUST Financial Advisors’s Praxis Precision Medicines PRAX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-90
Closed -$3K – 3517
2022
Q2 		$3K Buy
+90
New +$9.61K ﹤0.01% 4328
2022
Q1 		– Sell
-4
Closed -$1K – 5085
2021
Q4 		$1K Hold
4
– – ﹤0.01% 4616
2021
Q3 		$1K Buy
+4
New +$1.08K ﹤0.01% 4470
2021
Q2 		– Sell
-1
Closed – – 4626
2021
Q1 		$0 Buy
+1
New +$711 ﹤0.01% 4446

Other funds holding PRAX

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CAPTRUST Financial Advisors's PRAX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Praxis Precision Medicines (PRAX) in Q3 2022, closing a stake of 90 shares — an estimated $3K sold.

CAPTRUST Financial Advisors first reported a position in PRAX in Q1 2021 and held it in 4 quarters. The position peaked at $3K in Q2 2022. 108 funds tracked by Wall St. Rank hold PRAX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Praxis Precision Medicines position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 90 Praxis Precision Medicines shares in Q3 2022, an estimated $3K.
  • CAPTRUST Financial Advisors first reported a position in Praxis Precision Medicines in Q1 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Praxis Precision Medicines position peaked at $3K in Q2 2022.
  • 108 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.